Caribou Biosciences

CRISPR Therapeutics
Biotech

Appeals court reignites row over CRISPR discovery

Years after a body ruled in favor of teams behind Editas' IP, a court has found fault with the decision and sent the case back for reassessment.
Nick Paul Taylor May 13, 2025 8:00am
Caribou antlers sitting on ground with mountains in background

Caribou cuts 32% of staff, further purges cell therapy pipeline

Apr 24, 2025 9:55pm
Paraglider over Lake Tahoe

Vincerx acquisition leads to C-suite shake-up—Chutes & Ladders

Jan 3, 2025 8:30am
picture of a paraglider

CRISPR-focused Caribou christens new CMO—Chutes & Ladders

Aug 16, 2024 8:30am
layoffs cut staff reduction workforce

Caribou cuts NK program, lays off 12% to fund CAR-T trials

Jul 17, 2024 5:41am
Photo of a parachutes opened with a dark blue sky in the background

John Cox gets new biotech CEO gig at Dyne—Chutes & Ladders

Mar 29, 2024 9:30am